We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Castlight (CSLT) to Report Q4 Earnings:What's in the Cards?
Read MoreHide Full Article
Castlight Health, Inc. (CSLT - Free Report) is set to report fourth-quarter 2017 results on Feb 21.
Notably, the company has beaten the Zacks Consensus Estimate is the trailing four quarters, with an average positive surprise of 40.54%. Last quarter, the company came up with a positive surprise of 28.57%.
Loss of 5 cents per share was in line with the year-ago quarter figure. Revenues increased 35.6% year over year to $34.6 million and also surpassed the Zacks Consensus Estimate of $34 million. Castlight stated that increasing rate of adoption, broadening product portfolio and operating efficiencies were the key catalysts.
Factors to Consider
Castlight’s software platform that assists organizations in gaining control over their health care costs is witnessing rapid adoption. This was evident from the top-line growth. Moreover, Castlight expects renewals to boost its annualized recurring revenues (“ARR”).
The Zacks Consensus Estimate for Professional Services segment revenues is around $3.2 million while that for Subscription revenues is about $33.1 million.
The company’s strategic acquisition of Jiff has strengthened its product portfolio. Cross-selling of products is also expanding customer base.
Moreover, partnerships with the likes of Livongo, Big Health, Hinge Health, Retrofit and Kurbo are likely to help the company rapidly penetrate a number of health markets. Additionally, integration of Castlight's comprehensive health navigation platform with Washington Health Alliance will expand customer base.
We believe all these factors to be key catalysts for the company’s fourth-quarter results. The Zacks Consensus Estimate for revenues and earnings are $36 million and negative 4 cents per share, respectively.
What Our Model Says
According to the Zacks model, a company with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) has a good chance of beating estimates if it also has a positive Earnings ESP. The Sell-rated stocks (Zacks Rank #4 or 5) are best avoided. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Castlight has a Zacks Rank #3 and an Earnings ESP of +7.69%. Consequently, our proven model shows that the company is likely to deliver a positive surprise this quarter.
Other Stocks to Consider
Here are some other top-ranked stocks that you may want to consider as our model shows that these too have the right combination of elements to deliver an earnings beat in their upcoming release.
Analog Devices (ADI - Free Report) has an Earnings ESP of +0.96% and a Zacks Rank #3.
Gogo Inc. (GOGO - Free Report) has an Earnings ESP of +2.80% and a Zacks Rank #3.
Can Hackers Put Money INTO Your Portfolio?
Earlier this month, credit bureau Equifax announced a massive data breach affecting 2 out of every 3 Americans. The cybersecurity industry is expanding quickly in response to this and similar events. But some stocks are better investments than others.
Zacks has just released Cybersecurity! An Investor’s Guide to help Zacks.com readers make the most of the $170 billion per year investment opportunity created by hackers and other threats. It reveals 4 stocks worth looking into right away.
Image: Bigstock
Castlight (CSLT) to Report Q4 Earnings:What's in the Cards?
Castlight Health, Inc. (CSLT - Free Report) is set to report fourth-quarter 2017 results on Feb 21.
Notably, the company has beaten the Zacks Consensus Estimate is the trailing four quarters, with an average positive surprise of 40.54%. Last quarter, the company came up with a positive surprise of 28.57%.
Loss of 5 cents per share was in line with the year-ago quarter figure. Revenues increased 35.6% year over year to $34.6 million and also surpassed the Zacks Consensus Estimate of $34 million. Castlight stated that increasing rate of adoption, broadening product portfolio and operating efficiencies were the key catalysts.
Factors to Consider
Castlight’s software platform that assists organizations in gaining control over their health care costs is witnessing rapid adoption. This was evident from the top-line growth. Moreover, Castlight expects renewals to boost its annualized recurring revenues (“ARR”).
The Zacks Consensus Estimate for Professional Services segment revenues is around $3.2 million while that for Subscription revenues is about $33.1 million.
Castlight Health, inc. Price and EPS Surprise
Castlight Health, inc. Price and EPS Surprise | Castlight Health, inc. Quote
The company’s strategic acquisition of Jiff has strengthened its product portfolio. Cross-selling of products is also expanding customer base.
Moreover, partnerships with the likes of Livongo, Big Health, Hinge Health, Retrofit and Kurbo are likely to help the company rapidly penetrate a number of health markets. Additionally, integration of Castlight's comprehensive health navigation platform with Washington Health Alliance will expand customer base.
We believe all these factors to be key catalysts for the company’s fourth-quarter results. The Zacks Consensus Estimate for revenues and earnings are $36 million and negative 4 cents per share, respectively.
What Our Model Says
According to the Zacks model, a company with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) has a good chance of beating estimates if it also has a positive Earnings ESP. The Sell-rated stocks (Zacks Rank #4 or 5) are best avoided. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Castlight has a Zacks Rank #3 and an Earnings ESP of +7.69%. Consequently, our proven model shows that the company is likely to deliver a positive surprise this quarter.
Other Stocks to Consider
Here are some other top-ranked stocks that you may want to consider as our model shows that these too have the right combination of elements to deliver an earnings beat in their upcoming release.
Micron Technology (MU - Free Report) has an Earnings ESP of +1.83% and a Zacks Rank #3. You can see the complete list of today’s Zacks #1 Rank stocks here.
Analog Devices (ADI - Free Report) has an Earnings ESP of +0.96% and a Zacks Rank #3.
Gogo Inc. (GOGO - Free Report) has an Earnings ESP of +2.80% and a Zacks Rank #3.
Can Hackers Put Money INTO Your Portfolio?
Earlier this month, credit bureau Equifax announced a massive data breach affecting 2 out of every 3 Americans. The cybersecurity industry is expanding quickly in response to this and similar events. But some stocks are better investments than others.
Zacks has just released Cybersecurity! An Investor’s Guide to help Zacks.com readers make the most of the $170 billion per year investment opportunity created by hackers and other threats. It reveals 4 stocks worth looking into right away.
Download the new report now>>